Philbert Nzeyimana

Mr. Philbert Nzeyimana

Pharmacy, Institut National de Santé Publique du Burundi, Bujumbura, Bujumbura Mairie, Burundi
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2025 in Plant Science Today
Verified
Journal Article
Open access
PDF file
GRGautier Roko
Gautier Roko
MNMartial Nounagnon
Martial Nounagnon
ABAbdoulaye Oury Barry
Abdoulaye Oury Barry
NANadège Adoukè AGBODJATO
Nadège Adoukè AGBODJATO
ICIfeoma Chidebe
Ifeoma Chidebe
EMEmeje Martins
Emeje Martins
Ageratum conyzoides L. (Asteraceae) is a medicinal plant widely distributed in tropical and subtropical regions. It is an integral part of traditional medicine in Africa, Asia and South America, where it is used to treat a wide range of diseases, such as diabetes, skin diseases, respiratory disorders, inflammation, burns, wounds, diarrhea, fever, muscle pain, reproductive problems, leprosy and other ailments. This review aimed to consolidate and critically analyze scientific studies on A. conyzoides to assess its therapeutic potential and safety. A narrative literature review was carried out using databases such as Google Scholar, Scopus and PubMed, covering the period from 2023 to 2025. Keywords related to the plant’s traditional uses, phytochemistry, pharmacological properties and toxicology were used. Only studies providing experimental or ethnobotanical data in English were included. Results show that A. conyzoides contains diverse bioactive compounds such as flavonoids, alkaloids, terpenes, chromenes and phenolic acids. These are associated with anti-inflammatory, antimicrobial, antidiabetic, anticancer, antioxidant and wound-healing activities. In particular, flavonoids and chromenes contribute to the plant’s antioxidant and anti-inflammatory effects, while pyrrolizidine alkaloids may cause hepatotoxicity at high doses. Overall, the available data corroborate many of the traditional uses of this plant. However, the lack of standardized extraction methods and the limited nature of preclinical and clinical data justify further studies to validate its efficacy and ensure the safety of its therapeutic use.

12 December 2025 in Journal of Biochemistry, Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
HAHareg Zewdu Alehegn
Hareg Zewdu Alehegn
Philbert NzeyimanaPhilbert Nzeyimana
Philbert Nzeyimana
ADAlhagie Drammeh
Alhagie Drammeh
RARukayya Garba Anchau
Rukayya Garba Anchau
JAJibrin Abdulkadir
Jibrin Abdulkadir
Jibrin Muhammad YelwaJibrin Muhammad Yelwa
Jibrin Muhammad Yelwa
Human microbiome is a significant point of contact for immunity building and prevents contagious diseases. If the microbiome is disrupted, especially due to broad-spectrum antibiotics, it will make infections more likely to occur with complex disease outcomes like Clostridium difficile colitis. Pharmacological interventions such as probiotics, prebiotics, and microbiome therapy strategies one to two generations ahead and the transplant method, FMT, are all very promising solutions for infection prevention and treatment through their effects on the microbiome. The purpose of this review is to evaluate the present state of knowledge concerning the relationship between the microbiome and infections and to present some of the new pharmacological microbiome modulation strategies. It gives examples where microbiome-targeted therapy has led to a reduction in the infectious risk, a very welcome situation regarding hospitalized/immunocompromised patients, for instance. Nevertheless, though a lot of people are fascinated by the area, problems such as personalized varieties one by one, institutional prejudices, and regulatory unknowns are still the main issues for clinical translating. The use of microbiome-modulating clinical practices is backed up by the research that goes with infectious disease therapies. These fields' growth will necessarily involve collaboration among scientists from different areas and massive error-free clinical trials to confirm the effectiveness and safety of the treatments in different subcategories of patients and infection strains.

15 January 2026 in Asian Journal of Biochemistry
Verified
Journal Article
Closed access
GRGautier Roko
Gautier Roko
MNMartial Nounagnon
Martial Nounagnon
ABAbdoulaye Oury Barry
Abdoulaye Oury Barry
NANadège Adoukè AGBODJATO
Nadège Adoukè AGBODJATO
EGEric Ghigo
Eric Ghigo
MEMartins Emeje
Martins Emeje

1 October 2025
Verified
Book Chapter
Closed access
PDF file
Jibrin Muhammad YelwaJibrin Muhammad Yelwa
Jibrin Muhammad Yelwa
HMHaruna Musa
Haruna Musa
ADAlhagie Drammeh
Alhagie Drammeh
KKKalu M. Kalu
Kalu M. Kalu
Philbert NzeyimanaPhilbert Nzeyimana
Philbert Nzeyimana
HAHusaina G. Anchau
Husaina G. Anchau